Table Info

Table 1.

Distribution of descriptive characteristics of the patients

Characteristics		Min-Max	Mean ± SD
Age (years)		22–53	39.43 ± 8.54
Duration of symptoms (years)		2–32	14.51 ± 8.62
Headache duration (hours)		4–24	14.73 ± 9.24
Frequency of migraine (days)		2.5–16	11.37 ± 4.15
Pain severity (VAS)		6–10	9.35 ± 1.05
Lost time at work (days)		1–15	5.56 ± 3.34
		n	%
Gender	Female	141	68.1
Gender	Male	66	31.9
Aura	Present	143	69.1
Aura	Absent	64	30.9

VAS: visual analog scale

Declarations

Author contributions

AV: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. SK: Conceptualization, Writing—original draft, Writing—review & editing. TÇ: Investigation, Writing—review & editing, Validation, Supervision. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study was approved by the Institutional Review Board of Haydarpaşa Numune Educational and Research Hospital Istanbul with the study Identification Number (HNEAH-KAEK 2012/40).

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

The data are not publicly available due to government restrictions on patient privacy.

Funding

Not applicable.

Copyright

References

Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9:369–79. [DOI] [PubMed]

Ozdemir G, Aygül R, Demir R, Ozel L, Ertekin A, Ulvi H. Migraine prevalence, disability, and sociodemographic properties in the eastern region of Turkey: a population-based door-to-door survey. Turk J Med Sci. 2014;44:624–9. [PubMed]

Headache Classification Committee of the International Headache Society (IHS). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1–96. [PubMed]

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808. [DOI] [PubMed]

Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005;128:2068–77. [DOI] [PubMed]

Silberstein SD. Preventive Migraine Treatment. Continuum (Minneap Minn). 2015;21:973–89. [DOI] [PubMed] [PMC]

Behin F, Lipton RB, Bigal M. Migraine and intranasal contact point headache: is there any connection? Curr Pain Headache Rep. 2006;10:312–5. [DOI] [PubMed]

Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31:183–4. [PubMed]

Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117:S35–40. [DOI] [PubMed]

10.

Stammberger H, Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol Suppl. 1988;134:3–23. [DOI] [PubMed]

11.

Buzzi MG, Moskowitz MA. The trigemino-vascular system and migraine. Pathol Biol (Paris). 1992;40:313–7. [PubMed]

12.

Cady RK, Schreiber CP. Sinus headache: a clinical conundrum. Otolaryngol Clin North Am. 2004;37:267–88. [DOI] [PubMed]

13.

Rozen TD. Intranasal contact point headache: missing the “point” on brain MRI. Neurology. 2009;72:1107. [DOI] [PubMed]

14.

Novak VJ, Makek M. Pathogenesis and surgical treatment of migraine and neurovascular headaches with rhinogenic trigger. Head Neck. 1992;14:467–72. [DOI] [PubMed]

15.

Bolger SM. The Nasal Septum and Concha Bullosa. Otolaryngol Clin North AM. 1989;22:291–306. [PubMed]

16.

Yazici ZM, Cabalar M, Sayin I, Kayhan FT, Gurer E, Yayla V. Rhinologic evaluation in patients with primary headache. J Craniofac Surg. 2010;21:1688–91. [DOI] [PubMed]

17.

Abu-Samra M, Gawad OA, Agha M. The outcomes for nasal contact point surgeries in patients with unsatisfactory response to chronic daily headache medications. Eur Arch Otorhinolaryngol. 2011;268:1299–304. [DOI] [PubMed]

18.

Mehle ME, Kremer PS. Sinus CT scan findings in “sinus headache” migraineurs. Headache. 2008;48:67–71. [DOI] [PubMed]

19.

Cady RK, Schreiber CP. Sinus problems as a cause of headache refractoriness and migraine chronification. Curr Pain Headache Rep. 2009;13:319–25. [DOI] [PubMed]

20.

Reilly JS. The sinusitis cycle. Otolaryngol Head Neck Surg. 1990;103:856–62. [DOI] [PubMed]

21.

Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427–36. [DOI] [PubMed]

22.

Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, et al. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache. 2012;52:3–17. [DOI] [PubMed]